Pancreatic Cancer Research

ResearcherUniversity of FlorenceActive in the last 2 years

Annarosa Arcangeli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6317-9648; OpenAlex author ID A5029640604. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
46
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/apha.70183↗
  2. Retraction Note: Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. Last author DOI 10.1007/s11051-025-06264-8↗
  3. Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. Last author DOI 10.1038/s41420-025-02321-2↗
  4. Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers15072013↗
  5. Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection. Last author DOI 10.3791/63123↗
  6. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy. Co-author DOI 10.3389/fphar.2020.586599↗
  7. Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells. Co-author DOI 10.3390/cancers12030640↗
  8. The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. Last author DOI 10.3390/cancers11020135↗
  9. A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts. Last author DOI 10.1038/s41598-017-01256-8↗
  10. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/bjc.2015.28↗
  11. Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer. Co-author DOI 10.1098/rstb.2013.0101↗
  12. Development of novel anti-Kv 11.1 antibody-conjugated PEG-TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells. Last author DOI 10.1007/s11051-013-2111-6↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudia Duranti · 5 shared papers, 2019–2025 · strength 0.76
  2. Tiziano Lottini · 3 shared papers, 2021–2025 · strength 0.56
  3. Albrecht Schwab · 3 shared papers, 2019–2026 · strength 0.40
  4. Angelica Sette · 3 shared papers, 2013–2025 · strength 0.36
  5. Jolanda Spadavecchia · 2 shared papers, 2013–2025 · strength 0.32
  6. Verena Hofschröer · 2 shared papers, 2020–2026 · strength 0.31
  7. Ivana Novak · 2 shared papers, 2020–2026 · strength 0.30
  8. Stefano Coppola · 2 shared papers, 2019–2023 · strength 0.25
  9. Lara Magni · 2 shared papers, 2019–2020 · strength 0.20
  10. Elena Lastraioli · 2 shared papers, 2015–2023 · strength 0.19
  11. Roberto Coppola · 2 shared papers, 2015–2023 · strength 0.19
  12. Sagar S. Manoli · 3 shared papers, 2015–2019 · strength 0.19
  13. Pawel Swietach · 1 shared paper, 2026 · strength 0.19
  14. Sofie Hagelund · 1 shared paper, 2026 · strength 0.19
  15. Laura Mezzanotte · 1 shared paper, 2026 · strength 0.19
  16. Zoltán Pethő · 1 shared paper, 2026 · strength 0.19
  17. Tiago M. A. Carvalho · 1 shared paper, 2026 · strength 0.19
  18. Stephan J. Reshkin · 1 shared paper, 2026 · strength 0.19
  19. Torsten Hechler · 1 shared paper, 2026 · strength 0.19
  20. Rosa Angela Cardone · 1 shared paper, 2026 · strength 0.19
  21. Julie Schnipper · 1 shared paper, 2026 · strength 0.19
  22. Wiktoria Błaszczak · 1 shared paper, 2026 · strength 0.19
  23. Frauke Alves · 1 shared paper, 2026 · strength 0.19
  24. Ganga Deshar · 1 shared paper, 2026 · strength 0.19
  25. Renata Ialchina · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.